P504: CLINICAL MUTATIONAL ANALYSIS BY NEXT-GENERATION SEQUENCING AND REAL-LIFE VALIDATION OF THE REVISED 2017 EUROPEAN LEUKEMIANET GENETIC RISK STRATIFICATION IN AML PATIENTS

P504: CLINICAL MUTATIONAL ANALYSIS BY NEXT-GENERATION SEQUENCING AND REAL-LIFE VALIDATION OF THE REVISED 2017 EUROPEAN LEUKEMIANET GENETIC RISK STRATIFICATION IN AML PATIENTS

Bibliographic Details
Main Authors:	C. Aparicio Pérez, F. Salas Hernandez, A. C. Gonzalez Teomiro, F. Jimenez Najar, I. Fernandez Camacho, C. Martin Calvo, J. Sánchez García, J. Serrano López
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844904.12001.16

Similar Items

S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: Marius Bill, et al.
Published: (2023-08-01)

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
by: Schuurhuis, G, et al.
Published: (2018)

P507: AGREEMENT BETWEEN REAL-WORLD PHYSICIAN RESPONSE ASSESSMENT AND THE 2017 EUROPEAN LEUKEMIANET (ELN) CRITERIA IN ACUTE MYELOID LEUKEMIA (AML): A COMPARATIVE ANALYSIS
by: P. A. Patel, et al.
Published: (2022-06-01)

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia
by: Ga-Young Song, et al.
Published: (2024-04-01)

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification
by: Stefan Wilop, et al.
Published: (2016-09-01)

The new European leukemianet recommendations for treating CML
by: Rüdiger Hehlmann
Published: (2020-10-01)

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
by: Claudia Sargas, et al.
Published: (2023-05-01)

Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine
by: Mihee Kim, et al.
Published: (2024-12-01)

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
by: Era L. Pogosova-Agadjanyan, et al.
Published: (2020-08-01)

European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera
by: Douglas Tremblay, et al.
Published: (2022-06-01)

Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial
by: Jorge E. Cortes, et al.
Published: (2022-10-01)

COMPARATIVE ANALYSIS BETWEEN 2010, 2017 AND 2022 EUROPEAN LEUKEMIA NET RISK STRATIFICATION RESULTS IN PATIENTS WITH AML
by: FK Marques, et al.
Published: (2023-10-01)

Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET
by: Kai Wille, et al.
Published: (2023-05-01)

P412: TRANSCRIPTOMIC CLASSIFICATION, RISK STRATIFICATION AND THERAPY SELECTION IN AML
by: Jeppe Severens, et al.
Published: (2023-08-01)

504 absolutely essential words /
by: Bromberg, Murray, author, et al.
Published: (1996)

Workshop manual for Peugeot 504
by: 6648 Intereurope, Ltd
Published: (1972)

The inventory of Manninni (Cth 504)
by: Silvin Košak
Published: (1978-12-01)

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
by: van de Loosdrecht, A, et al.
Published: (2009)

Assessment of 2022 European LeukemiaNet risk classification system in real‐world cohort from China
by: Enbo Chen, et al.
Published: (2023-12-01)

MULTICENTRE VALIDATION OF A REPRODUCIBLE FLOW CYTOMETRIC SCORE FOR THE DIAGNOSIS OF LOWRISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A EUROPEAN LeukemiaNET STUDY
by: Picone, C, et al.
Published: (2011)

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response
by: K. H. Begna, et al.
Published: (2022-01-01)

RHS 504-Perumahan dan Teknologi
by: PPPB, Pusat Pengajian Perumahan Bangunan & Perancangan (School of Houu
Published: (2002)

Peugeot 504 owners workshop manual/
by: 268832 Haynes, John Harold, et al.
Published: (1975)

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study.
by: Della Porta, MG, et al.
Published: (2012)

P442: SPINK2 PROTEIN EXPRESSION QUANTIFIED BY IMMUNOHISTOCHEMISTRY REFINES RISK STRATIFICATION AND PREDICTS THERAPY OUTCOMES IN AML
by: H. A. Pitts, et al.
Published: (2022-06-01)

The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy
by: Lourdes M. Mendez, et al.
Published: (2019-11-01)

RLD 504 - HORTIKULTUR LANDSKAP APRIL 07.
by: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Published: (2007)

KAA 504 - KAEDAH ELEKTROKIMIA MAC 05.
by: PPSK, Pusat Pengajian Sains Kimia
Published: (2005)

RLD 504 - HORTIKULTUR LANDSKAP FEB 01.
by: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Published: (2001)

CSI504 - COMPUTER NETWORKS - OKT. 2000
by: PPSKOM, Pusat Pengajian Sains Komputer
Published: (2000)

CSI504 – RANGKAIAN KOMPUTER - OKT. 2000
by: PPSKOM, Pusat Pengajian Sains Komputer
Published: (2000)

CSI504 – COMPUTER NETWORKS - SEPT. 2001
by: PPSKOM, Pusat Pengajian Sains Komputer
Published: (2001)

CSI504 – RANGKAIAN KOMPUTER - SEPT. 2001
by: PPSKOM, Pusat Pengajian Sains Komputer
Published: (2001)

RLD 504 - Hortikultur Landskap - June 2013
by: PPPBP, Pusat Pengajian Perumahan Bangunan Dan Perancangan
Published: (2013)

CSI 504 - RANGKAIAN KOMPUTER SEPT 1999.
by: PPSKOM, Pusat Pengajian Sains Komputer
Published: (1999)

CSI 504 - COMPUTER NETWORKS SEPT 1999.
by: PPSKOM, Pusat Pengajian Sains Komputer
Published: (1999)

Colecistectomía laparoscópica. Experiencia con 504 casos
by: Juan Domínguez, et al.
Published: (1994-04-01)

Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project
by: Mohamed A. Yassin MBBS, MSc, et al.
Published: (2021-04-01)

Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML
by: Thomas Oellerich, et al.
Published: (2019-08-01)

PB1867: ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 – REAL-LIFE EXPERIENCE IN THE REDEFINITION OF EUROPEAN LEUKEMIANET RISK CLASSIFICATION
by: Rita S Gomes, et al.
Published: (2023-08-01)